Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on April 29, 2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citigroup Global Markets India, acting as the Manager to the Offer, has filed a disclosure with the Exchange showing the number of equity shares tendered by shareholders in the ongoing Open Offer for Sanofi Consumer Healthcare India as of April 29, 2025. This is a routine regulatory update required under takeover regulations to keep the market informed about the response to the open offer. The disclosure helps investors gauge how many shareholders have accepted the offer price so far. The Open Offer itself was triggered by an underlying acquisition transaction involving the company.
Shareholders who have not yet tendered can use this disclosure to assess market participation levels before deciding. Higher tendering may signal strong acceptance of the offer price, potentially driving the stock toward the offer price.